1AI 11.1% 1.0¢ algorae pharmaceuticals limited

I’d be comfortable if the price hovers around the high teens...

  1. 95 Posts.
    I’d be comfortable if the price hovers around the high teens until November.

    The 35% price rise during the month on high relative volume has certainly been enough to raise awareness among new investors / traders. I’m sure even if no actual purchase has yet been made LCT would have been added to a lot of watch lists during the past few weeks eagerly awaiting November’s announcement. This is based not only on the recent price spike but also looking at a longer term view, you’d struggle to find a better looking 3 year chart on any micro cap company.

    Because of this increased interest by investors as well as several mainstream publications well aware of this trial as reported on during June, I’m confident that LCT will no longer fly under radar and will receive a fair market valuation proportionate to the trial outcome.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.